[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345652-105":59,"doc-detail-345652-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dusp4-mediated-dephosphorylation-of-psmd14-enhances-psmd14-dependent-deubiquitination-of-micall2-and-promotes-malignant-progression-in-clear-cell-renal-cell-carcinoma","DUSP4-mediated dephosphorylation of PSMD14 - enhances PSMD14-dependent deubiquitination of MICALL2 and promotes malignant progression in clear cell renal cell carcinoma","","PSMD14 has been identified as an oncogene in multiple cancers, but its contribution to clear cell renal cell carcinoma (ccRCC) remained unclear. This study evaluated how PSMD14 influences ccRCC cell proliferation, migration, and invasion, using paired tumor and adjacent tissues, renal cell lines, RT-qPCR, Western blotting, functional assays, interaction studies, and an in vivo mouse model. Results show PSMD14 upregulation predicts poor outcomes and drives malignant progression via DUSP4-mediated dephosphorylation and MICALL2 deubiquitination.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dusp4-mediated-dephosphorylation-of-psmd14-enhances-psmd14-dependent-deubiquitination-of-micall2-and-promotes-malignant-progression-in-clear-cell-renal-cell-carcinoma/345652/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dusp4-mediated-dephosphorylation-of-psmd14-enhances-psmd14-dependent-deubiquitination-of-micall2-and-promotes-malignant-progression-in-clear-cell-renal-cell-carcinoma/345652.png","ImageObject",300,407,{"name":92,"@type":93},"Rowan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":19},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this study in clear cell renal cell carcinoma?","Question",{"text":112,"@type":113},"The study investigates how PSMD14 affects ccRCC malignant progression, particularly proliferation, migration, invasion, and the underlying molecular mechanism involving MICALL2 and DUSP4.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were the effects of PSMD14 evaluated experimentally?",{"text":117,"@type":113},"Paired tumor and adjacent tissues were analyzed, and ccRCC cell lines plus HK-2 cells were tested using RT-qPCR, Western blotting, CCK-8 and EdU assays, wound-healing and Transwell assays, and co-immunoprecipitation. An in vivo mouse model assessed tumor growth.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does DUSP4-mediated dephosphorylation play in the PSMD14–MICALL2 pathway?",{"text":121,"@type":113},"DUSP4 dephosphorylates PSMD14, enhancing its interaction with MICALL2. This amplification increases PSMD14-dependent MICALL2 deubiquitination and promotes ccRCC progression.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345652,1790219728,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":19,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514067415,"https://ap-avatar.wpscdn.com/avatar/100002539d78ffe74a7?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779092875211072502","Zeng et al. Journal of Translational Medicine (2026) 24:790  \n[https://doi.org/10.1186/s12967-026-08250-7](https://doi.org/10.1186/s12967-026-08250-7)  \nJournal of Translational Medicine  \nRESEARCH Open Access  \nDUSP4-mediated dephosphorylation of PSMD14 enhances PSMD14-dependent deubiquitination of MICALL2 and promotes malignant progression in clear cell renal cell carcinoma  \nXian-you Zeng1,2, Yong Nie1, Chang-yan Zhu3, Quan-liang Liu2, Qiu-shui Li2, Ji-lin Xie2, Shi-guang Yang2 and Lie-fu Ye 1*  \nAbstract  \nBackground PSMD14 has been identified as an oncogene in various cancers; however, its role in clear cell renal cell carcinoma (ccRCC) remains unclear. This study investigated the effects of PSMD14 on ccRCC cell proliferation, migration, and invasion.  \nMethods Thirty paired cancerous and adjacent non-cancerous tissues were collected from patients with ccRCC. The human normal renal tubular epithelial cell line HK-2 and ccRCC cell lines (KMRC-1, OS-RC-2, Caki-1, and 786-O) were used for in vitro experiments. The mRNA and protein expression levels of PSMD14, MICALL2, and DUSP4 were analyzed by RT-qPCR and Western blotting. Cell viability and proliferation were evaluated using the CCK-8 assay and EdU staining. Wound-healing and Transwell assays were performed to assess cell migration and invasion, respectively. Co-immunoprecipitation was conducted to verify molecular interactions between PSMD14 and MICALL2/DUSP4 . Immunoprecipitation was used to examine MICALL2 ubiquitination and PSMD14 phosphorylation. An in vivo ccRCC mouse model was established to assess tumor growth. Immunohistochemical staining was used to detect Ki67 and PSMD14 expression in mouse tumor tissues.  \nResults PSMD14 was significantly upregulated in ccRCC tissues and was correlated with poor patient outcomes. PSMD14 knockdown inhibited ccRCC cell proliferation, migration, and invasion. PSMD14 suppressed MICALL2 ubiquitination and degradation, thereby increasing MICALL2 expression and promoting ccRCC malignant progression. Dephosphorylation of PSMD14 by DUSP4 enhanced its interaction with MICALL2 . Moreover, DUSP4-mediated dephosphorylation amplified the PSMD14-induced increase in MICALL2, further facilitating ccRCC progression. In vivo, PSMD14 knockdown inhibited ccRCC tumor development.  \n*Correspondence:  \nLie-fu Ye[yeliefu2025@163.com](yeliefu2025@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/licenses/by-nc-nd/4.0/.)  \nZeng et al. Journal of Translational Medicine (2026) 24:790 Page 2 of 17  \nConclusion DUSP4-mediated dephosphorylation of PSMD14 promotes ccRCC malignant progression by regulating MICALL2 deubiquitination, providing potential therapeutic targets for ccRCC treatment.  \nKeywords Clear cell renal cell carcinoma, DUSP4, MICALL2, PSMD14  \nIntroduction  \nClear cell renal cell carcinoma (ccRCC), a kidney maligna","cbCaieeWaINVvTnB","https://ap.wps.com/l/cbCaieeWaINVvTnB","pdf",22522954,17,"English","# Abstract\n# Background\n# Methods\n## In vitro experiments\n## Interaction and ubiquitination assays\n## In vivo model\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the main focus of this study in clear cell renal cell carcinoma?\",\"answer\":\"The study investigates how PSMD14 affects ccRCC malignant progression, particularly proliferation, migration, invasion, and the underlying molecular mechanism involving MICALL2 and DUSP4.\"},{\"question\":\"How were the effects of PSMD14 evaluated experimentally?\",\"answer\":\"Paired tumor and adjacent tissues were analyzed, and ccRCC cell lines plus HK-2 cells were tested using RT-qPCR, Western blotting, CCK-8 and EdU assays, wound-healing and Transwell assays, and co-immunoprecipitation. An in vivo mouse model assessed tumor growth.\"},{\"question\":\"What role does DUSP4-mediated dephosphorylation play in the PSMD14–MICALL2 pathway?\",\"answer\":\"DUSP4 dephosphorylates PSMD14, enhancing its interaction with MICALL2. This amplification increases PSMD14-dependent MICALL2 deubiquitination and promotes ccRCC progression.\"}]","DUSP4-mediated dephosphorylation of PSMD14 - enhances PSMD14-dependent deubiquitination of MICALL2 and promotes malignant progression in clear cell renal cell carcinoma | PDF",1790058461,43,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/05cb28a5d5ece9e1c2f5545862128603.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4d5fe3cc59c6116d76eb5157afa6c356.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/71b89e4263fd834c903c96f9ae6ce2c2.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2c6ca4fd9edc4e371c1caabbb47a6a7.webp",980,1306]